A comparison of expression of IRAK1 in metastatic clinical tumor samples showed that the expression and activity of IRAK1 increased when the tumor was metastatic, thus became more sensitive to IRAK1 inhibition (12). The gene discussed is IRAK1; the disease is neoplasm.